# US 8,278,281 B2 · Triazole compounds and methods of making and using the same

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 8,278,281 B2
- Document ID: US8278281B2
- Status: Granted
- Kind: B2
- Application number: 11/990,883
- Filed: 2006-08-24
- Published: 2010-01-21
- Granted: 2012-10-02
- Earliest claimed: 2005-08-24
- Assignees: Rib-X Pharmaceuticals, Inc.
- Inventors: Ashoke Bhattacharjee; Zoltan F. Kanyo; Edward C. Sherer
- Web page: https://patentgrep.com/patent/US8278281B2

## CPC

- C07H 17/08: Hetero rings containing eight or more ring members, e.g. erythromycins
- A61P 1/00: Drugs for disorders of the alimentary tract or the digestive system
- A61P 1/10: Laxatives
- A61P 17/00: Drugs for dermatological disorders
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P 31/00: Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P 31/04: Antibacterial agents
- A61P 31/10: Antimycotics
- A61P 31/12: Antivirals
- A61P 33/00: Antiparasitic agents
- A61P 35/00: Antineoplastic agents
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C07H 17/00: Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H: SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS (derivatives of aldonic or saccharic acids C07C, C07D; aldonic acids, saccharic acids C07C59/105, C07C59/285; cyanohydrins C07C255/16; glycals C07D; compounds of unknown constitution C07G; polysaccharides, derivatives thereof C08B; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; sugar industry C13)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention provides triazole macrocyclic compounds useful as therapeutic agents. More particularly, these compounds are useful as anti-infective, anti-proliferative, anti-inflammatory, and prokinetic agents. The compounds have the following structure: wherein T is the macrocyclic part.

## Claims

### Claim 1

A compound having the structure:
or a pharmaceutically acceptable salt, ester, or N-oxide thereof,
wherein
A is selected from: (a) a C1-6 alkyl group, (b) a C2-6 alkenyl group, (c) a C2-6 alkynyl group, (d) a C3-12 saturated, unsaturated, or aromatic carbocycle, (e) a 3-12 membered saturated, unsaturated, or aromatic heterocycle containing one or more nitrogen, oxygen or sulfur atoms, (f) H, (g) —OH, (h) —SH, (i) F, (j) Cl, (k) Br, (l) I, (m) —CF3, (n) —CN, (o) —N3, (p) —NO2, (q) —NR6(CR6R6)tR9, (r) —OR9, (s) —S(CR6R6)tR9, (t) —C(O)(CR6R6)tR9, (u) —OC(O)(CR6R6)tR9, (v) —OC(O)O(CR6R6)tR9, (w) —SC(O)(CR6R6)tR9, (x) —C(O)O(CR6R6)tR9, (y) —NR6C(O)(CR6R6)tR9, (z) —C(O)NR6(CR6R6)tR9, (aa) —C(═NR6)(CR6R6)tR9, (bb) —C(═NNR6R6)(CR6R6)tR9, (cc) —C[═NNR6C(O)R6](CR6R6)tR9, (dd) —NR6C(O)O(CR6R6)tR9, (ee) —OC(O)NR6(CR6R6)tR9, (ff) —NR6C(O)NR6(CR6R6)tR9, (gg) —NR6S(O)p(CR6R6)tR9, (hh) —S(O)pNR6(CR6R6)tR9, (ii) —NR6R6, (jj) —SR6, (kk) —S(O)R6, (ll) —NR6C(O)R6, (mm) —Si(R13)3, and (nn) —C(═O)H,
wherein (a)-(e) optionally are substituted with one or more R14 groups;
T is a 14- or 15-membered macrolide connected via a macrocyclic ring carbon atom;
X is selected from —OR15 and —SR15;
R1 and R3 independently are selected from: (a) H, (b) a C1-6 alkyl group, (c) a C2-6 alkenyl group, (d) a C2-6 alkynyl group, (e) —C(O)R5, (f) —C(O)OR5, (g) —C(O)—NR4R4, (h) —C(S)R5, (i) —C(S)OR5, (j) —C(O)SR5, and (k) —C(S)—NR4R4;
alternatively, R1 and R3 are taken together with the oxygen to which R1 is attached, the nitrogen to which R3 is attached and the two intervening carbons to form a 5 or 6 membered ring, said ring being optionally substituted with one or more R5;
R2 is hydrogen or —OR12;
R4, at each occurrence, independently is selected from:
(a) H, (b) a C1-6 alkyl group, (c) a C2-6 alkenyl group, (d) a C2-6 alkynyl group, (e) a C6-10 saturated, unsaturated, or aromatic carbocycle, (f) a 3-12 membered saturated, unsaturated, or aromatic heterocycle containing one or more heteroatoms selected from nitrogen, oxygen, and sulfur, (g) —C(O)—C1-6 alkyl, (h) —C(O)—C2-6 alkenyl, (i) —C(O)—C2-6 alkynyl, (j) —C(O)—C6-10 saturated, unsaturated, or aromatic carbocycle, (k) —C(O)-3-12 membered saturated, unsaturated, or aromatic heterocycle containing one or more heteroatoms selected from nitrogen, oxygen, and sulfur, (l) —C(O)O—C1-6 alkyl, (m) —C(O)O—C2-6 alkenyl, (n) —C(O)O—C2-6 alkynyl, (o) —C(O)O—C6-10 saturated, unsaturated, or aromatic carbocycle, (p) —C(O)O-3-12 membered saturated, unsaturated, or aromatic heterocycle containing one or more heteroatoms selected from nitrogen, oxygen, and sulfur, and (q) —C(O)NR6R6,
wherein any of (b)-(p) optionally is substituted with one or more R5 groups;
alternatively, NR6R6 forms a 3-7 membered saturated, unsaturated or aromatic ring including the nitrogen atom to which the R6 groups are attached, wherein said ring is optionally substituted at a position other than the nitrogen atom to which the R6 groups are attached, with one or more substituents selected from O, S(O)p, N, and NR8;
R5 is selected from:
(a) R7, (b) a C1-8 alkyl group, (c) a C2-8 alkenyl group, (d) a C2-8 alkynyl group, (e) a C3-12 saturated, unsaturated, or aromatic carbocycle, and (f) a 3-12 membered saturated, unsaturated, or aromatic heterocycle containing one or more heteroatoms selected from nitrogen, oxygen, and sulfur, or two R5 groups, when present on the same carbon atom can be taken together with the carbon atom to which they are attached to form a spiro 3-6 membered carbocyclic ring or heterocyclic ring containing one or more heteroatoms selected from nitrogen, oxygen, and sulfur,
wherein any of (b)-(f) immediately above optionally is substituted with one or more R7 groups;
R6, at each occurrence, independently is selected from:
(a) H, (b) a C1-6 alkyl group, (c) a C2-6 alkenyl group, (d) a C2-6 alkynyl group, (e) a C3-10 saturated, unsaturated, or aromatic carbocycle, and (f) a 3-10 membered saturated, unsaturated, or aromatic heterocycle containing one or more heteroatoms selected from nitrogen, oxygen, and sulfur,
wherein any of (b)-(f) optionally is substituted with one or more moieties selected from:
(aa) a carbonyl group, (bb) a formyl group, (cc) F, (dd) Cl, (ee) Br, (ff) I, (gg) CN, (hh) NO2, (ii) —OR8, (jj) —S(O)pR8, (kk) —C(O)R8, (ll) —C(O)OR8, (mm) —OC(O)R8, (nn) —C(O)NR8R8, (oo) —OC(O)NR8R8, (pp) —C(═NR8)R8, (qq) —C(R8)(R8)OR8, (rr) —C(R8)2OC(O)R8, (ss) —C(R8)(OR8)(CH2)rNR8R8, (tt) —NR8R8, (uu) —NR8OR8, (vv) —NR8C(O)R8, (ww) —NR8C(O)OR8, (xx) —NR8C(O)NR8R8, (yy) —NR8S(O)rR8, (zz) —C(OR8)(OR8)R8, (ab) —C(R8)2NR8R8, (ac) ═NR8, (ad) —C(S)NR8R8, (ae) —NR8C(S)R8, (af) —OC(S)NR8R8, (ag) —NR8C(S)OR8, (ah) —NR8C(S)NR8R8, (ai) —SC(O)R8, (aj) a C1-8 alkyl group, (ak) a C2-8 alkenyl group, (al) a C2-8 alkynyl group, (am) a C1-8 alkoxy group, (an) a C1-8 alkylthio group, (ao) a C1-8 acyl group, (ap) —CF3, (aq) —SCF3-, (ar) a C3-10 saturated, unsaturated, or aromatic carbocycle, and (as) a 3-10 membered saturated, unsaturated, or aromatic heterocycle containing one or more heteroatoms selected from nitrogen, oxygen, and sulfur;
alternatively, NR6R6 forms a 3-10 membered saturated, unsaturated or aromatic ring including the nitrogen atom to which the R6 groups are attached wherein said ring is optionally substituted at a position other than the nitrogen atom to which the R6 groups are bonded, with one or more moieties selected from —O, S(O)p, N, and NR8;
alternatively, CR6R6 forms a carbonyl group;
R7, at each occurrence, is selected from:
(a) H, (b) ═O, (c) ═S, (d) F, (e) Cl, (f) Br, (g) I, (h) —CF3, (i) —CN, (j) —N3, (k) —NO2, (l) —NR6(CR6R6)tR9, (m) —OR9, (n) —S(O)pC(R6R6)tR9, (o) —C(O)(CR6R6)tR9, (p) —OC(O)(CR6R6)tR9, (q)—SC(O)(CR6R6)tR9, (r) —C(O)O(CR6R6)tR9, (s) —NR6C(O)(CR6R6)tR9, (t) —C(O)NR6(CR6R6)tR9, (u) —C(═NR6)(CR6R6)tR9, (v) —C(═NNR6R6)(CR6R6)tR9, (w) —C(═NNR6C(O)R6)(CR6R6)tR9, (x) —C(═NOR9)(CR6R6)tR9, (y) —NR6C(O)O(CR6R6)tR9, (z) —OC(O)NR6(CR6R6)tR9, (aa) —NR6C(O)NR6(CR6R6)tR9, (bb) —NR6S(O)p(CR6R6)tR9, (cc) —S(O)pNR6(CR6R6)tR9, (dd) —NR6S(O)pNR6(CR6R6)tR9, (ee) —NR6R6, (ff) —NR6(CR6R6), (gg) —OH, (hh) —NR6R6, (ii) —OCH3, (jj) —S(O)pR6, (kk) —NC(O)R6, (ll) a C1-6 alkyl group, (mm) a C2-6 alkenyl group, (nn) a C2-6 alkynyl group, (oo) —C3-10 saturated, unsaturated, or aromatic carbocycle, and (pp) 3-10 membered saturated, unsaturated, or aromatic heterocycle containing one or more heteroatoms selected from nitrogen, oxygen, and sulfur,
wherein any of (ll)-(pp) optionally is substituted with one or more R9 groups; alternatively, two R7 groups taken together form —O(CH2)uO—;
R8 is selected from:
(a) H, (b) a C1-6 alkyl group, (c) a C2-6 alkenyl group, (d) a C2-6 alkynyl group, (e) a C3-10 saturated, unsaturated, or aromatic carbocycle, (f) a 3-10 membered saturated, unsaturated, or aromatic heterocycle containing one or more heteroatoms selected from nitrogen, oxygen, and sulfur, (g) —C(O)—C1-6 alkyl, (h) —C(O)—C1-6 alkenyl, (i) —C(O)—C1-6 alkynyl, (j) —C(O)—C3-10 saturated, unsaturated, or aromatic carbocycle, and (k) —C(O)-3-10 membered saturated, unsaturated, or aromatic heterocycle containing one or more heteroatoms selected from nitrogen, oxygen, and sulfur,
wherein any of (c)-(k) optionally is substituted with one or more moieties selected from: (aa) H, (bb) F, (cc) Cl, (dd) Br, (ee) I, (ff) CN, (gg) NO2, (hh) OH, (ii) NH2, (jj) NH(C1-6 alkyl), (kk) N(C1-6 alkyl)2, (ll) a C1-6 alkoxy group, (mm) an aryl group, (nn) a substituted aryl group, (oo) a heteroaryl group, (pp) a substituted heteroaryl group, and (qq) a C1-6 alkyl group optionally substituted with one or more moieties selected from an aryl group, a substituted aryl group, a heteroaryl group, a substituted heteroaryl group, F, Cl, Br, I, CN, NO2, CF3, SCF3, and OH;
R9, at each occurrence, independently is selected from:
(a) R10, (b) a C1-6 alkyl group, (c) a C2-6 alkenyl group, (d) a C2-6 alkynyl group, (e) a C3-10 saturated, unsaturated, or aromatic carbocycle, and (f) a 3-10 membered saturated, unsaturated, or aromatic heterocycle containing one or more heteroatoms selected from nitrogen, oxygen, and sulfur,
wherein any of (b)-(f) optionally is substituted with one or more R10 groups;
R10, at each occurrence, independently is selected from:
(a) H, (b) ═O, (c) F, (d) Cl, (e) Br, (f) I, (g) —CF3, (h) —CN, (i) —NO2, (j) —NR6R6, (k) —OR6, (l) —S(O)pR6, (m) —C(O)R6, (n) —C(O)OR6, (o) —OC(O)R6, (p) NR6C(O)R6, (q) —C(O)NR6R6, (r) —C(═NR6)R6, (s) —NR6C(O)NR6R6, (t) —NR6S(O)pR6, (u) —S(O)pNR6R6, (v) —NR6S(O)pNR6R6, (w) a C1-6 alkyl group, (x) a C2-6 alkenyl group, (y) a C2-6 alkynyl group, (z) a C3-10 saturated, unsaturated, or aromatic carbocycle, and (aa) a 3-10 membered saturated, unsaturated, or aromatic heterocycle containing one or more heteroatoms selected from nitrogen, oxygen, and sulfur,
wherein any of (w)-(aa) optionally is substituted with one or more moieties selected from R6, F, Cl, Br, I, CN, NO2, —OR6, —NH2, —NH(C1-6 alkyl), —N(C1-6 alkyl)2, a C1-6 alkoxy group, a C1-6 alkylthio group, and a C1-6 acyl group;
R11 at each occurrence, independently is selected from:
(a) H, (b) F, (c) Cl, (d) Br, (e) I, (f) CN, (g) NO2, (h) OR8, (i) —S(O)pR8, (j) —C(O)R8, (k) —C(O)OR8, (l) —OC(O)R8, (m) —C(O)NR8R8, (n) —OC(O)NR8R8, (o) —C(═NR8)R8, (p) —C(R8)(R8)OR8, (q) —C(R8)2OC(O)R8, (r) —C(R8)(OR8)(CH2)rNR8R8, (s) —NR8R8, (t) —NR8OR8, (u) —NR8C(O)R8, (v) —NR8C(O)OR8, (w) —NR8C(O)NR8R8, (x) —NR8S(O)pR8, (y) —C(OR8)(OR8)R8, (z) —C(R8)2NR8R8, (aa) —C(S)NR8R8, (bb) —NR8C(S)R8, (cc) —OC(S)NR8R8, (dd) —NR8C(S)OR8, (ee) —NR8C(S)NR8R8, (ff) —SC(O)R8, (gg) —N3, (hh) —Si(R13)3, (ii) a C1-8 alkyl group, (jj) a C2-8 alkenyl group, (kk) a C2-8 alkynyl group, (ll) a C3-10 saturated, unsaturated, or aromatic carbocycle, and (mm) a 3-10 membered saturated, unsaturated, or aromatic heterocycle containing one or more heteroatoms selected from nitrogen, oxygen, and sulfur, wherein (ii)-(mm) optionally are substituted with one or more R5 groups;
R12 is selected from:
(a) H, (b) a C1-6 alkyl group, (c) a C2-6 alkenyl group, (d) a C2-6 alkynyl group, (e) —C(O)R5, (f) —C(O)OR5, (g) —C(O)—NR4R4, (h) —C(S)R5, (i) —C(S)OR5, (j) —C(O)SR5, (k) —C(S)—NR4R4, (l) a C3-10 saturated, unsaturated, or aromatic carbocycle, (m) a 3-10 membered saturated, unsaturated, or aromatic heterocycle containing one or more heteroatoms selected from -nitrogen, oxygen, and sulfur, (n) a —(C1-6 alkyl)-C3-10 saturated, unsaturated, or aromatic carbocycle, and (o) a —(C1-6 alkyl)-3-10 membered saturated, unsaturated, or aromatic heterocycle containing one or more heteroatoms selected from nitrogen, oxygen, and sulfur,
wherein (a)-(d) and (l)-(o) optionally are substituted with one or more R5 groups;
R13 at each occurrence, is independently selected from (a) —C1-6 alkyl and (b) —O—(C1-6 alkyl);
R14 at each occurrence is independently selected from:
(a) H, (b) F, (c) Cl, (d) Br, (e) I, (l) CN, (g) NO2, (h) OR8, (i) —S(O)pR8, (j) —C(O)R8, (k) —C(O)OR8, (l) —OC(O)R8, (m) —C(O)NR8R8, (n) —OC(O)NR8R8, (o) —C(═NR8)R8, (p) —C(R8)(R8)OR8, (q) —C(R8)2OC(O)R8, (r) —C(R8)(OR8)(CH2)rNR8R8, (s) —NR8R8, (t) —NR8OR8, (u) —NR8C(O)R8, (v) —NR8C(O)OR8, (w) —NR8C(O)NR8R8, (x) —NR8S(O)pR8, (y) —C(OR8)(OR8)R8, (z) —C(R8)2NR8R8, (aa) —C(S)NR8R8, (bb) —NR8C(S)R8, (cc) —OC(S)NR8R8, (dd) —NR8C(S)OR8, (ee) —NR8C(S)NR8R8, (ff) —SC(O)R8, (gg) —N3, (hh) —Si(R13)3, (ii) a C1-8 alkyl group, (jj) a C2-8 alkenyl group, (kk) a C2-8 alkynyl group, (ll) a C3-10 saturated, unsaturated, or aromatic carbocycle, and (mm) a 3-10 membered saturated, unsaturated, or aromatic heterocycle containing one or more heteroatoms selected from nitrogen, oxygen, and sulfur, wherein (ii)-(mm) optionally are substituted with one or more R5 groups;
alternatively, two R14 groups are taken together to form (a) ═O, (b) ═S, (c) ═NR8, (e) ═NOR8;
R15 is C1-6 alkyl, optionally substituted with from 1 to 13 fluorine atoms;
n at each occurrence is 0, 1, 2, 3, or 4;
p at each occurrence is 0, 1, or 2;
r at each occurrence is 0, 1, or 2;
t at each occurrence is 0, 1, or 2;
and u at each occurrence is 1, 2, 3, or 4.

### Claim 2 (depends on 1)

The compound according to claim 1 having the structure:
or a pharmaceutically acceptable salt, ester, or N-oxide thereof.

### Claim 3 (depends on 1)

The compound according to claim 1 having the structure:
or a pharmaceutically acceptable salt, ester, or N-oxide thereof.

### Claim 4 (depends on 1)

The compound according to claim 1, or a pharmaceutically acceptable salt, ester, or N-oxide thereof, wherein R15 is C1-3 alkyl, optionally substituted with from 1 to 7 fluorines.

### Claim 5 (depends on 1)

The compound according to claim 1, or a pharmaceutically acceptable salt, ester, or N-oxide thereof, wherein R15 is C1-2 alkyl, optionally substituted with from 1 to 5 fluorines.

### Claim 6 (depends on 1)

The compound according to claim 1, or a pharmaceutically acceptable salt, ester, or N-oxide thereof, wherein R15 is selected from —CH3, —CH2F, —CHF2, and —CF3.

### Claim 7 (depends on 6)

The compound according to claim 6, or a pharmaceutically acceptable salt, ester, or N-oxide thereof, wherein R15 is —CH3.

### Claim 8 (depends on 1)

The compound according to claim 1 having the structure:
or a pharmaceutically acceptable salt, ester, or N-oxide thereof.

### Claim 9 (depends on 1)

The compound according to claim 1, or a pharmaceutically acceptable salt, ester, or N-oxide thereof, wherein n is 1 or 2.

### Claim 10 (depends on 1)

The compound according to claim 1, or a pharmaceutically acceptable salt, ester, or N-oxide thereof, wherein n is 1.

### Claim 11 (depends on 1)

The compound according to claim 1, or a pharmaceutically acceptable salt, ester, or N-oxide thereof, wherein R11 is F.

### Claim 12 (depends on 1)

The compound according to claim 1, or a pharmaceutically acceptable salt, ester, or N-oxide thereof, wherein n is 0.

### Claim 13 (depends on 1)

The compound according to claim 1, or a pharmaceutically acceptable salt, ester, or N-oxide thereof, wherein A is selected from: (a) a C1-6 alkyl group, (b) a C2-6 alkenyl group, (c) a C2-6 alkynyl group, (d) a C3-12 saturated, unsaturated, or aromatic carbocycle, (e) a 3-12 membered saturated, unsaturated, or aromatic heterocycle containing one or more nitrogen, oxygen or sulfur atoms, (f) —CF3, (g) —NR6(CR6R6)tR9, (h) —OR9, (i) —S(CR6R6)tR9, (j) —C(O)(CR6R6)tR9, (k) —OC(O)(CR6R6)tR9, (l) —OC(O)O(CR6R6)tR9, (m) —SC(O)(CR6R6)tR9, (n) —C(O)O(CR6R6)tR9, (o) —NR6C(O)(CR6R6)tR9, (p) —C(O)NR6(CR6R6)tR9, (q) —C(═NR6)(CR6R6)tR9, (r) —C(═NNR6R6)(CR6R6)tR9, (s) —C[═NNR6C(O)R6](CR6R6)tR9, (t) —NR6C(O)O(CR6R6)tR9, (u) —OC(O)NR6(CR6R6)tR9, (v) —NR6C(O)NR6(CR6R6)tR9, (w) —NR6S(O)p(CR6R6)tR9, (x) —S(O)pNR6(CR6R6)tR9, (y) —NR6R6, (z) —SR6, (aa) —S(O)R6, and (bb) —NR6C(O)R6, wherein (a)-(e) optionally are substituted with one or more R14 groups.

### Claim 14 (depends on 1)

The compound according to claim 1, or a pharmaceutically acceptable salt, ester, or N-oxide thereof, wherein A is selected from: (a) a C1-6 alkyl group, (b) a C2-6 alkenyl group, (c) a C2-6 alkynyl group, (d) a C3-12 saturated, unsaturated, or aromatic carbocycle, (e) a 3-12 membered saturated, unsaturated, or aromatic heterocycle containing one or more nitrogen, oxygen or sulfur atoms,
wherein (a)-(e) optionally are substituted with one or more R14 groups.

### Claim 15 (depends on 1)

The compound according to claim 1, or a pharmaceutically acceptable salt, ester, or N-oxide thereof, wherein A is selected from (a) —NR6(CR6R6)tR9, (b) —OR9, (c) —S(CR6R6)tR9, (d) —C(O)(CR6R6)tR9, (e) —OC(O)(CR6R6)tR9, (f) —OC(O)O(CR6R6)tR9, (g) —SC(O)(CR6R6)tR9, (h) —C(O)O(CR6R6)tR9, (i) —NR6C(O)(CR6R6)tR9, (j) —C(O)NR6(CR6R6)tR9, (k) —C(═NR6)(CR6R6)tR9, (l) —C(═NNR6R6)(CR6R6)tR9, (m) —C[═NNR6C(O)R6](CR6R6)tR9, (n) —NR6C(O)O(CR6R6)tR9, (o) —OC(O)NR6(CR6R6)tR9, (p) —NR6C(O)NR6(CR6R6)tR9, (q) —NR6S(O)p(CR6R6)tR9, (r) —S(O)pNR6(CR6R6)tR9, (s) —NR6R6, (t) —SR6, (u) —S(O)R6, and (v) —NR6C(O)R6.

### Claim 16 (depends on 1)

The compound according to claim 1, or a pharmaceutically acceptable salt, ester, or N-oxide thereof, wherein T is
wherein:
M is selected from:
(a) —C(O)—, (b) —CH(—OR114)—, (c) —NR114—CH2—, (d) (e) —CH(NR114R114)—, (f) —C(═NNR114R114)—, (g) —NR114—C(O)—, (h) —C(O)NR114—, (i) —C(═NR114)—, (j) —CR115R115—, and (k) —C(═NOR127)—;
R100 is selected from (a) H, (b) F, (c) Cl, (d) Br, (e) —SR114, and (f) C1-6 alkyl, wherein (f) optionally is substituted with one or more R115 groups;
R101 is selected from:
(a) H, (b) Cl, (c) F, (d) Br, (e) I, (f) —NR114R114, (g) —NR114C(O)R114, (h) —OR114, (i) —OC(O)R114, (j) —OC(O)OR114, (k) —OC(O)NR114R114, (l) —O—C1-6 alkyl, (m) —OC(O)—C1-6 alkyl, (n) —OC(O)O—C1-6 alkyl, (o) —OC(O)NR114—C1-6 alkyl, (p) C1-6 alkyl, (q) C1-6 alkenyl, and (r) C1-6 alkynyl,
wherein any of (l)-(r) optionally is substituted with one or more R115 groups;
R102 is (a) H, (b) F, (c) Cl, (d) Br, (e) —SR114, (f) C1-6 alkyl, wherein (f) optionally is substituted with one or more R115 groups;
R103 is selected from:
(a) H, (b) —OR114, (c) —O—C1-6 alkyl-R115, (d) —OC(O)R114, (e) —OC(O)—C1-6 alkyl-R115, (f) —OC(O)OR114, (g) —OC(O)O—C1-6 alkyl-R115, (h) —OC(O)NR114R114, (i) —OC(O)NR114—C1-6 alkyl-R115, and
alternatively, R102 and R103 taken together with the carbon to which they are attached form (a) a carbonyl group or (b) a 3-7 membered saturated, unsaturated or aromatic carbocyclic or heterocyclic ring which can optionally be substituted with one or more R114 groups; alternatively, R101 and R103 taken together are a single bond between the respective carbons to which these two groups are attached thereby creating a double bond between the carbons to which R100 and R102 are attached;
alternatively, R101 and R103 taken together with the carbons to which they are attached form a 3-membered saturated, unsaturated or aromatic carbocyclic or heterocyclic ring which can optionally be substituted with one or more R114 groups;
R104 is selected from:
(a) H, (b) R114, (c) —C(O)R114, (d) —C(O)OR114, (e) —C(O)NR114R114, (f) —C1-6 alkyl-K—R114, (g) —C2-6 alkenyl-K—R114, and (h) —C2-6 alkynyl-K—R114;
K is selected from:
(a) —C(O)—, (b) —C(O)O—, (c) —C(O)NR114—, (d) —C(═NR114)—, (e) —C(═NR114)O—, (f) —C(═NR114)NR114—, (g) —OC(O)—, (h) —OC(O)O—, (i) —OC(O)NR114—, (j) —NR114C(O)—, (k) —NR114C(O)O—, (l) —NR114C(O)NR114—, (m) —NR114C(═NR114)NR114—, and (n) —S(O)p—;
alternatively, R103 and R104, taken together with the atoms to which they are bonded, form:
wherein R135 and R136 are selected from (a) hydrogen, (b) C1-6 alkyl, (c) C2-6 alkenyl, (d) C2-6 alkynyl, (d) C3-14 saturated, unsaturated or aromatic carbocycle, (e) 3-14 membered saturated, unsaturated or aromatic heterocycle containing one or more oxygen, nitrogen, or sulfur atoms, (f) F, (g) Br, (h) I, (i) OH, and (j) —N3, wherein (b) through (e) are optionally substituted with one or more R117;
alternatively, R135 and R136 taken together form ═O, ═S, ═NR114, ═NOR114, ═NR114, and ═N—NR114R114;
wherein V is selected from (a) —(C1-C4-alkyl)-, (b) —(C4-alkenyl)-, (c) O, (d) S, and (e) NR114, wherein (a) and (b) are optionally further substituted with one or more R117;
R105 is selected from:
(a) R114, (b) —OR114, (c) —NR114R114, (d) —O—C1-6 alkyl-R115, (e) —C(O)—R114, (f) —C(O)—C1-6 alkyl-R115, (g) —OC(O)—R114, (h) —OC(O)—C1-6 alkyl-R115, (i) —OC(O)O—R114, (j) —OC(O)O—C1-6 alkyl-R115, (k) —OC(O)NR114R114; (l) —OC(O)NR114—C1-6 alkyl-R115, (m) —C(O)—C2-6 alkenyl-R115, and (n) —C(O)—C2-6 alkynyl-R115;
alternatively, R104 and R105, taken together with the atoms to which they are bonded, form
wherein
Q is CH or N, and R126 is —OR114, —NR114 or R114;
alternatively, R104 and R105, taken together with the atoms to which they are bonded, form:
wherein
i) R101 is as defined above;
ii) alternatively, R101 and R109 taken together with the carbon to which they are attached form a carbonyl group;
iii) alternatively, R101 and R109 taken together form the group —O(CR116R116)uO—;
alternatively, R104 and R105, taken together with the atoms to which they are bonded, form:
wherein in the preceding structure the dotted line indicates an optional double bond,
i) R130 is —OH or R114,
ii) R131 is —OH or R114,
iii) alternatively, R130 and R131 taken together with the carbons to which they are attached form a 3-7 membered saturated, unsaturated or aromatic carbocyclic or heterocyclic ring which can optionally be substituted with one or more R114 groups;
iv) alternatively, R130 and the carbon to which it is attached or R131 and the carbon to which it is attached are each independently —C(═O)—;
alternatively, R105, R132 and M, taken together with the atoms to which they are attached, form:
R106 is selected from:
(a) —OR114, (b) —C1-6 alkoxy-R115, (c) —C(O)R114, (d) —OC(O)R114, (e) —OC(O)OR114, (f) —OC(O)NR114R114, and (g) NR114R114;
alternatively, R105 and R106 taken together with the atoms to which they are attached form a 5-membered ring by attachment to each other through a chemical moiety selected from:
(a) —OC(R115)2O—, (b) —OC(O)O—, (c) —OC(O)NR114—, (d) —NR114C(O)O—, (e) —OC(O)NOR114—, (f) —NOR114—C(O)O—, (g) —OC(O)NNR114R114—, (h) —NNR114R114—C(O)O—, (i) —OC(O)C(R115)2—, (j) —C(R115)2C(O)O—, (k) —OC(S)O—, (l) —OC(S)NR114—, (m) —NR114C(S)O—, (n) —OC(S)NOR114—, (o)—NOR114—C(S)O—, (p) —OC(S)NNR114R114—, (q) —NNR114R114—C(S)O—, (r) —OC(S)C(R115)2—, and (s) —C(R115)2C(S)O—;
alternatively, R105, R106, and R133 taken together with the atoms to which they are attached form:
alternatively, M, R105, and R106 taken together with the atoms to which they are attached form:
wherein in the preceding structure the dotted line indicates an optional double bond,
wherein J1 and J2 are selected from hydrogen, Cl, F, Br, I, OH, —C1-6 alkyl, and —O(C1-6 alkyl) or taken together form ═O, ═S and ═NR114, ═NOR114, ═NR114, and ═N—NR114R114;
alternatively, M and R104 taken together with the atoms to which they are attached form:
wherein U is selected from (a) —(C4-alkyl)- and (b) —(C4-alkenyl)-, wherein (a) and (b) are optionally further substituted with one or more R117;
alternatively, M and R105 are taken together with the atoms to which they are attached to form:
R107 is selected from:
(a) H, (b) —C1-4 alkyl, (c) —C2-4 alkenyl, which can be further substituted with C1-12 alkyl or one or more halogens, (d) —C2-4 alkynyl, which can be further substituted with C1-12 alkyl or one or more halogens, (e) aryl or heteroaryl, which can be further substituted with C1-12 alkyl or one or more halogens, (f) —C(O)H, (g) —COOH, (h) —CN, (i) —COOR114, (j) —C(O)NR114R114, (k) —C(O)R114, and (l) —C(O)SR114, wherein (b) is further substituted with one or more substituents selected from (aa) —OR114, (bb) halogen, (cc) —SR114, (dd) C1-12 alkyl, which can be further substituted with halogen, hydroxyl, C1-6 alkoxy, or amino, (ee) —OR114, (ff) —SR114, (gg) —NR114R114, (hh) —CN, (ii) —NO2, (jj) —NC(O)R114, (kk) —COOR114, (ll) —N3, (mm) ═N—O—R114, (nn) ═NR114, (oo) ═N—NR114R114, (pp) ═N—NH—C(O)R114, and (qq) ═N—NH—C(O)NR114R114;
alternatively R106 and R107 are taken together with the atom to which they are attached to form an epoxide, a carbonyl, an olefin, or a substituted olefin, or a C3-C7 carbocyclic, carbonate, or carbamate, wherein the nitrogen of said carbamate can be further substituted with a C1-C6 alkyl;
R108 is selected from:
(a) C1-6 alkyl, (b) C2-6 alkenyl, and (c) C2-6 alkynyl,
wherein any of (a)-(c) optionally is substituted with one or more R114 groups;
R112 is selected from H, OH, and OR114;
R114, at each occurrence, independently is selected from:
(a) H, (b) C1-6 alkyl, (c) C2-6 alkenyl, (d) C2-6 alkynyl, (e) C6-10 saturated, unsaturated, or aromatic carbocycle, (f) 3-12 membered saturated, unsaturated, or aromatic heterocycle containing one or more heteroatoms selected from nitrogen, oxygen, and sulfur, (g) —C(O)—C1-6 alkyl, (h) —C(O)—C2-6 alkenyl, (i) —C(O)—C2-6 alkynyl, (j) —C(O)—C6-10 saturated, unsaturated, or aromatic carbocycle, (k) —C(O)-3-12 membered saturated, unsaturated, or aromatic heterocycle containing one or more heteroatoms selected from nitrogen, oxygen, and sulfur, (l) —C(O)O—C1-6 alkyl, (m) —C(O)O—C2-6 alkenyl, (n) —C(O)O—C2-6 alkynyl, (o) —C(O)O—C6-10 saturated, unsaturated, or aromatic carbocycle, (p) —C(O)O-3-12 membered saturated, unsaturated, or aromatic heterocycle containing one or more heteroatoms selected from nitrogen, oxygen, and sulfur, (q) —C(O)NR116R116, (r) —NR116CO—C2-6 alkyl, (s) —NR116CO—C6-10 saturated, unsaturated, or aromatic carbocycle, and (t) —NR116C(O)-3-12 membered saturated, unsaturated, or aromatic heterocycle containing one or more heteroatoms selected from nitrogen, oxygen, and sulfur
wherein any of (b)-(t) optionally is substituted with one or more R115 groups,
wherein one or more non-terminal carbon moieties of any of (b)-(d)
optionally is replaced with oxygen, S(O)p, or —NR116;
alternatively, NR114R114 forms a 3-7 membered saturated, unsaturated or aromatic ring including the nitrogen atom to which the R114 groups are bonded and optionally one or more moieties selected from O, S(O)p, N, and NR118;
R115 is selected from:
(a) R117, (b) C1-8 alkyl, (c) C2-8 alkenyl, (d) C2-8 alkynyl, (e) C3-12 saturated, unsaturated, or aromatic carbocycle, and (f) 3-12 membered saturated, unsaturated, or aromatic heterocycle containing one or more heteroatoms selected from nitrogen, oxygen, and sulfur,
wherein any of (b)-(f) optionally is substituted with one or more R117 groups;
R116, at each occurrence, independently is selected from:
(a) H, (b) C1-6 alkyl, (c) C2-6 alkenyl, (d) C2-6 alkynyl, (e) C3-10 saturated, unsaturated, or aromatic carbocycle, and (f) 3-10 membered saturated, unsaturated, or aromatic heterocycle containing one or more heteroatoms selected from nitrogen, oxygen, and sulfur,
wherein one or more non-terminal carbon moieties of any of (b)-(d) optionally is replaced with oxygen, S(O)p, or —NR114, wherein any of (b)-(f) optionally is substituted with one or more moieties selected from:
(aa) carbonyl, (bb) formyl, (cc) F, (dd) Cl, (ee) Br, (ff) I, (gg) CN, (hh) N3, (ii) NO2, (jj) OR118, (kk) —S(O)pR118, (ll) —C(O)R118, (mm) —C(O)OR118, (nn) —OC(O)R118, (oo) —C(O)NR118R118, (pp) —OC(O)NR118R118, (qq) —C(═NR118)R118, (rr) —C(R118)(R118)OR118, (ss) —C(R118)2OC(O)R118, (tt) —C(R118)(OR118)(CH2)rNR118R118, (uu) —NR118R118; (vv) —NR118OR118, (ww) —NR118C(O)R118, (xx) —NR118C(O)OR118, (yy) —NR118C(O)NR118R118, (zz) —NR118S(O)rR118, (ab) —C(OR118)(OR118)R118, (ac) —C(R118)2NR118R118, (ad) ═NR118, (ae) —C(S)NR118R118, (af) —NR118C(S)R118, (ag) —OC(S)NR118R118, (ah) —NR118C(S)OR118, (ai) —NR118C(S)NR118R118, (aj) —SC(O)R118, (ak) C1-8 alkyl, (al) C2-8 alkenyl, (am) C2-8 alkynyl, (an) C1-8 alkoxy, (ao) C1-8 alkylthio, (ap) C1-8 acyl, (aq) saturated, unsaturated, or aromatic C3-10 carbocycle, and (ar) saturated, unsaturated, or aromatic 3-10 membered heterocycle containing one or more heteroatoms selected from nitrogen, oxygen, and sulfur;
alternatively, NR116R116 forms a 3-10 membered saturated, unsaturated or aromatic ring including the nitrogen atom to which the R116 groups are attached and optionally one or more moieties selected from O, S(O)p, N, and NR118;
alternatively, CR116R116 forms a carbonyl group;
R117, at each occurrence, is selected from:
(a) H, (b) ═O, (c) F, (d) Cl, (e) Br, (f) I, (g) (CR116R116)rCF3, (h) (CR116R116)rCN, (i) (CR116R116)rNO2, (j) (CR116R116)rNR116(CR116R116)tR119, (k) (CR116R116)rOR119, (l) (CR116R116)rS(O)p(CR116R116)tR119, (m) (CR116R116)rC(O)(CR116R116)tR119, (n) (CR116R116)rOC(O)(CR116R116)tR119, (o) (CR116R116)rSC(O)(CR116R116)tR119, (p) (CR116R116)rC(O)O(CR116R116)tR119, (q) (CR116R116)rNR116C(O)(CR116R116)tR119, (r) (CR116R116)rC(O)NR116(CR116R116)tR119), (s) (CR116R116)rC(═NR116)(CR116R116)tR119, (t) (CR116R116)rC(═NNR116R116)(CR116R116)tR119, (u) (CR116R116)rC(═NNR116C(O)R116)(CR116R116)tR119, (v) (CR116R116)rC(═NOR119)(CR116R116)tR119, (w) (CR116R116)rNR116C(O)O(CR116R116)tR119, (x) (CR116R116)rOC(O)NR116(CR116R116)tR119, (y) (CR116R116)rNR116C(O)NR116(CR116R116)tR116, (z) (CR116R116)rNR116S(O)p(CR116R116)tR119, (aa) (CR116R116)rS(O)pNR116(CR116R116)tR119, (bb) (CR116R116)rNR116S(O)pNR116(CR116R116)tR119, (cc) (CR116R116)rNR116R116, (dd) C1-6 alkyl, (ee) C2-6 alkenyl, (ff) C2-6 alkynyl, (gg) (CR116R116)r—C3-10 saturated, unsaturated, or aromatic carbocycle, and (hh) (CR116R116)r-3-10 membered saturated, unsaturated, or aromatic heterocycle containing one or more heteroatoms selected from nitrogen, oxygen, and sulfur,
wherein any of (dd)-(hh) optionally is substituted with one or more R119 groups;
alternatively, two R117 groups form —O(CH2)uO—;
R118 is selected from:
(a) H, (b) C1-6 alkyl, (c) C2-6 alkenyl, (d) C2-6 alkynyl, (e) C3-10 saturated, unsaturated, or aromatic carbocycle, (f) 3-10 membered saturated, unsaturated, or aromatic heterocycle containing one or more heteroatoms selected from -nitrogen, oxygen, and sulfur, (g) —C(O)—C1-6 alkyl, (h) —C(O)—C1-6 alkenyl, (i) —C(O)—C1-6 alkynyl, (j) —C(O)—C3-10 saturated, unsaturated, or aromatic carbocycle, and (k) —C(O)-3-10 membered saturated, unsaturated, or aromatic heterocycle containing one or more heteroatoms selected from nitrogen, oxygen, and sulfur,
wherein any of (b)-(k) optionally is substituted with one or more moieties selected from: (aa) H, (bb) F, (cc) Cl, (dd) Br, (ee) I, (ff) CN, (gg) NO2, (hh) OH, (ii) NH2, (jj) NH(C1-6 alky(l), (kk) N(C1-6 alky(l)2, (ll) C1-6 alkoxy, (mm) aryl, (nn) substituted aryl, (oo) heteroaryl, (pp) substituted heteroaryl, and (qq) C1-6 alkyl, optionally substituted with one or more moieties selected from -aryl, substituted aryl, heteroaryl, substituted heteroaryl, F, Cl, Br, I, CN, NO2, and OH;
R119, at each occurrence, independently is selected from:
(a) R120, (b) C1-6 alkyl, (c) C2-6 alkenyl, (d) C2-6 alkynyl, (e) C3-10 saturated, unsaturated, or aromatic carbocycle, and (f) 3-10 membered saturated, unsaturated, or aromatic heterocycle containing one or more heteroatoms selected from -nitrogen, oxygen, and sulfur;
R120, at each occurrence, independently is selected from:
(a) H, (b) ═O, (c) F, (d) Cl, (e) Br, (f) I, (g) (CR116R116)rCF3, (h) (CR116R116)rCN, (i) (CR116R116)rNO2, (j) (CR116R116)rNR116R116, (k) (CR116R116)rOR114, (l) (CR116R116)rS(O)pR116, (m) (CR116R116)rC(O)R116, (n) (CR116R116)rC(O)OR116, (o) (CR116R116)rOC(O)R116, (p) (CR116R116)rNR116C(O)R116, (q) (CR116R116)rC(O)NR116R116, (r) (CR116R116)rC(═NR116)R116, (s) (CR116R116)rNR116C(O)NR116R116, (t) CR116R116)rNR116S(O)pR116, (u) (CR116R116)rS(O)pNR116R116, (v) (CR116R116)rNR116S(O)pR116, (w) C1-6 alkyl, (x) C2-6 alkenyl, (y) C2-6 alkynyl, (z) (CR116R116)r—C3-10 saturated, unsaturated, or aromatic carbocycle, and (aa) (CR116R116)r-3-10 membered saturated, unsaturated, or aromatic heterocycle containing one or more heteroatoms selected from -nitrogen, oxygen, and sulfur,
wherein any of (w)-(aa) optionally is substituted with one or more moieties selected from: R116, F, Cl, Br, I, CN, NO2, —OR116, —NH2, —NH(C1-6 alkyl), —N(C1-6 alkyl)2, C1-6 alkoxy, C1-6 alkylthio, and C1-6 acyl;
R121, at each occurrence, independently is selected from:
(a) H, (b) —OR118, (c) —O—C1-6 alkyl-OC(O)R118, (d) —O—C1-6 alkyl-OC(O)OR118, (e) —O—C1-6alkyl-OC(O)NR118R118, (f) —O—C1-6 alkyl-C(O)NR118R118, (g) —O—C1-6 alkyl-NR118C(O)R118, (h) —O—C1-6 alkyl-NR118C(O)OR118, (i) —O—C1-6 alkyl-NR118C(O)NR118R118, (j) —O—C1-6 alkyl-NR118C(═N(H)NR118R118, (k) —O—C1-6 alkyl-S(O)pR118, (l) —O—C2-6 alkenyl-OC(O)R118, (m) —O—-C2-6 alkenyl-OC(O)OR118, (n) —O—C2-6 alkenyl-OC(O)NR118R118, (o) —O—C2-6 alkenyl-C(O)NR118R118, (p) —O—C2-6 alkenyl-NR118C(O)R118, (q) —O—C2-6 alkenyl-NR118C(O)OR118, (r) —O—C2-6 alkenyl-NR118C(O)NR118R118, (s) —O—C2-6 alkenyl-NR118C(═N(H)NR118R118, (t) —O—C2-6 alkenyl-S(O)pR118, (u) —O—C2-6 alkynyl-OC(O)R118, (v) —O—C2-6 alkynyl-OC(O)OR118, (w) —O—C2-6 alkynyl-OC(O)NR118R118, (x) —O—C2-6 alkynyl-C(O)NR118R118, (y) —O—C2-6 alkynyl-NR118C(O)R118, (z) —O—C2-6 alkynyl-NR118C(O)OR118, (aa) —O—C2-6 alkynyl-NR118C(O)NR118R118, (bb) —O—C2-6 alkynyl-NR118C(═N(H)NR118R118, (cc) —O—C2-6 alkynyl-S(O)pR118; and (dd) —NR118R118;
alternatively, two R121 groups taken together form ═O, ═NOR118, or ═NNR118R118;
R109 is H or F;
R127 is R114, a monosaccharide or disaccharide (including amino sugars and halo sugar(s)), —(CH2)n—(O—CH2CH2—)m—O(CH2)pCH3, or —(CH2)n—(O—CH2CH2—)m—OH;
R128 is R114;
R129 is R114;
R110 is R114;
alternatively, R109 and R110 taken together with the carbons to which they are attached form:
alternatively, R128 and R129 together with the carbons to which they are attached form a 3-6 membered saturated, unsaturated or aromatic carbocyclic or heterocyclic ring which can optionally be substituted with one or more R114 groups;
R132, R133, and R134 are each independently selected from: (a) H, (b) F, (c) Cl, (d) Br, (e) —OR114, (f) —SR114, (g) —NR114R114, and (h) C1-6 alkyl, wherein (h) optionally is substituted with one or more R115 groups;
alternatively, R132 and R133 taken together form a carbon-carbon double bond;
alternatively, R133 and R134 taken together form ═O, ═S, ═NOR114, ═NR114, and ═N—NR114R114;
alternatively, R105 and R134 taken together with the carbons to which they are attached form a 3-membered ring, said ring optionally containing an oxygen or nitrogen atom, and said ring being optionally substituted with one or more R114 groups;
alternatively, when M is a carbon moiety, R134 and M taken together form a carbon-carbon double bond;
k, at each occurrence is 0, 1, or 2;
m, at each occurrence is 0, 1, 2, 3, 4, or 5;
n, at each occurrence is 1, 2, or 3;
p at each occurrence is 0, 1, or 2;
r at each occurrence is 0, 1, or 2;
t at each occurrence is 0, 1, or 2; and
u at each occurrence is 1, 2, 3, or 4.

### Claim 17 (depends on 16)

The compound according to claim 16, or a pharmaceutically acceptable salt, ester, or N-oxide thereof, wherein T is selected from:
where the dotted lines indicate optional double bonds.

### Claim 18 (depends on 16)

The compound according to claim 16, or a pharmaceutically acceptable salt, ester, or N-oxide thereof, wherein T is selected from:

### Claim 19 (depends on 1)

A compound according to claim 1, or a pharmaceutically acceptable salt, ester, or N-oxide thereof, wherein T is selected from T1 through T33:

### Claim 20

A compound selected from:
Compound
No.
Structure
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
Compound
T
A
R11
1000a
T1
H
H
1000b
T1
H
F
1000c
T2
H
H
1000d
T2
H
F
1000e
T3
H
H
1000f
T3
H
F
1000g
T4
H
H
1000h
T4
H
F
1001a
T1
CH3CH2CH2—
H
1001b
T1
CH3CH2CH2—
F
1001c
T2
CH3CH2CH2—
H
1001d
T2
CH3CH2CH2—
F
1001e
T3
CH3CH2CH2—
H
1001f
T3
CH3CH2CH2—
F
1001g
T4
CH3CH2CH2—
H
1001h
T4
CH3CH2CH2—
F
1002a
T1
CH2═CHCH2—
H
1002b
T1
CH2═CHCH2—
F
1002c
T2
CH2═CHCH2—
H
1002d
T2
CH2═CHCH2—
F
1002e
T3
CH2═CHCH2—
H
1002f
T3
CH2═CHCH2—
F
1002g
T4
CH2═CHCH2—
H
1002h
T4
CH2═CHCH2—
F
1003a
T1
HC≡CCH2—
H
1003b
T1
HC≡CCH2—
F
1003c
T2
HC≡CCH2—
H
1003d
T2
HC≡CCH2—
F
1003e
T3
HC≡CCH2—
H
1003f
T3
HC≡CCH2—
F
1003g
T4
HC≡CCH2—
H
1003h
T4
HC≡CCH2—
F
1004a
T1
H
1004b
T1
F
1004c
T2
H
1004d
T2
F
1004e
T3
H
1004f
T3
F
1004g
T4
H
1004h
T4
F
1005a
T1
H
1005b
T1
F
1005c
T2
H
1005d
T2
F
1005e
T3
H
1005f
T3
F
1005g
T4
H
1005h
T4
F
1006a
T1
H
1006b
T1
F
1006c
T2
H
1006d
T2
F
1006e
T3
H
1006f
T3
F
1006g
T4
H
1006h
T4
F
1007a
T1
H
1007b
T1
F
1007c
T2
H
1007d
T2
F
1007e
T3
H
1007f
T3
F
1007g
T4
H
1007h
T4
F
1008a
T1
H
1008b
T1
F
1008c
T2
H
1008d
T2
F
1008e
T3
H
1008f
T3
H
1008g
T4
H
1008h
T4
F
1009a
T1
H
1009b
T1
F
1009c
T2
H
1009d
T2
F
1009e
T3
H
1009f
T3
F
1009g
T4
H
1009h
T4
F
1010a
T1
H
1010b
T1
F
1010c
T2
H
1010d
T2
F
1010e
T3
H
1010f
T3
F
1010g
T4
H
1010h
T4
F
1011a
T1
H
1011b
T1
F
1011c
T2
H
1011d
T2
F
1011e
T3
H
1011f
T3
F
1011g
T4
H
1011h
T4
F
1012a
T1
H
1012b
T1
F
1012c
T2
H
1012d
T2
F
1012e
T3
H
1012f
T3
F
1012g
T4
H
1012h
T4
F
1013a
T1
H
1013b
T1
F
1013c
T2
H
1013d
T2
F
1013e
T3
H
1013f
T3
F
1013g
T4
H
1013h
T4
F
10140a
T1
H
1014b
T1
F
1014c
T2
H
1014d
T2
F
1014e
T3
H
1014f
T3
F
1014g
T4
H
1014h
T4
F
1015a
T1
H
1015b
T1
F
1015c
T2
H
1015d
T2
F
1015e
T3
H
1015f
T3
F
1015g
T4
H
1015h
T4
F
1016a
T1
HO—
H
1016b
T1
HO—
F
1016c
T2
HO—
H
1016d
T2
HO—
F
1016e
T3
HO—
H
1016f
T3
HO—
F
1016g
T4
HO—
H
1016h
T4
HO—
F
1017a
T1
HS—
H
1017b
T1
HS—
F
1017c
T2
HS—
H
1017d
T2
HS—
F
1017e
T3
HS—
H
1017f
T3
HS—
F
1017g
T4
HS—
H
1017h
T4
HS—
F
1018a
T1
F
H
1018b
T1
F
F
1018c
T2
F
H
1018d
T2
F
F
1018e
T3
F
H
1018f
T3
F
F
1018g
T4
F
H
1018h
T4
F
F
1019a
T1
Cl
H
1019b
T1
Cl
F
1019c
T2
Cl
H
1019d
T2
Cl
F
1019e
T3
Cl
H
1019f
T3
Cl
F
1019g
T4
Cl
H
1019h
T4
Cl
F
1020a
T1
Br
H
1020b
T1
Br
F
1020c
T2
Br
H
1020d
T2
Br
F
1020e
T3
Br
H
1020f
T3
Br
F
1020g
T4
Br
H
1020h
T4
Br
F
1021a
T1
I
H
1021b
T1
I
F
1021c
T2
I
H
1021d
T2
I
F
1021e
T3
I
H
1021f
T3
I
F
1021g
T4
I
H
1021h
T4
I
F
1022a
T1
F3C—
H
1022b
T1
F3C—
F
1022c
T2
F3C—
H
1022d
T2
F3C—
F
1022e
T3
F3C—
H
1022f
T3
F3C—
F
1022g
T4
F3C—
H
1022h
T4
F3C—
F
1023a
T1
NC—
H
1023b
T1
NC—
F
1023c
T2
NC—
H
1023d
T2
NC—
F
1023e
T3
NC—
H
1023f
T3
NC—
F
1023g
T4
NC—
H
1023h
T4
NC—
F
1024a
T1
N3—
H
1024b
T1
N3—
F
1024c
T2
N3—
H
1024d
T2
N3—
F
1024e
T3
N3—
H
1024f
T3
N3—
F
1024g
T4
N3—
H
1024h
T4
N3—
F
1025a
T1
NO2—
H
1025b
T1
NO2—
F
1025c
T2
NO2—
H
1025d
T2
NO2—
F
1025e
T3
NO2—
H
1025f
T3
NO2—
F
1025g
T4
NO2—
H
1025h
T4
NO2—
F
1026a
T1
(CH3)2N—
H
1026b
T1
(CH3)2N—
F
1026c
T2
(CH3)2N—
H
1026d
T2
(CH3)2N—
F
1026e
T3
(CH3)2N—
H
1026f
T3
(CH3)2N—
F
1026g
T4
(CH3)2N—
H
1026h
T4
(CH3)2N—
F
1027a
T1
CH3O—
H
1027b
T1
CH3O—
F
1027c
T2
CH3O—
H
1027d
T2
CH3O—
F
1027e
T3
CH3O—
H
1027f
T3
CH3O—
F
1027g
T4
CH3O—
H
1027h
T4
CH3O—
F
1028a
T1
CH3S—
H
1028b
T1
CH3S—
F
1028c
T2
CH3S—
H
1028d
T2
CH3S—
F
1028e
T3
CH3S—
H
1028f
T3
CH3S—
F
1028g
T4
CH3S—
H
1028h
T4
CH3S—
F
1029a
T1
CH3S(═O)—
H
1029b
T1
CH3S(═O)—
F
1029c
T2
CH3S(═O)—
H
1029d
T2
CH3S(═O)—
F
1029e
T3
CH3S(═O)—
H
1029f
T3
CH3S(═O)—
F
1029g
T4
CH3S(═O)—
H
1029h
T4
CH3S(═O)—
F
1030a
T1
CH3S(═O)2—
H
1030b
T1
CH3S(═O)2—
F
1030c
T2
CH3S(═O)2—
H
1030d
T2
CH3S(═O)2—
F
1030e
T3
CH3S(═O)2—
H
1030f
T3
CH3S(═O)2—
F
1030g
T4
CH3S(═O)2—
H
1030h
T4
CH3S(═O)2—
F
1031a
T1
HC(═O)—
H
1031b
T1
HC(═O)—
F
1031c
T2
HC(═O)—
H
1031d
T2
HC(═O)—
F
1031e
T3
HC(═O)—
H
1031f
T3
HC(═O)—
F
1031g
T4
HC(═O)—
H
1031h
T4
HC(═O)—
F
1032a
T1
CH3C(═O)—
H
1032b
T1
CH3C(═O)—
F
1032c
T2
CH3C(═O)—
H
1032d
T2
CH3C(═O)—
F
1032e
T3
CH3C(═O)—
H
1032f
T3
CH3C(═O)—
F
1032g
T4
CH3C(═O)—
H
1032h
T4
CH3C(═O)—
F
1033a
T1
CH3OC(═O)—
H
1033b
T1
CH3OC(═O)—
F
1033c
T2
CH3OC(═O)—
H
1033d
T2
CH3OC(═O)—
F
1033e
T3
CH3OC(═O)—
H
1033f
T3
CH3OC(═O)—
F
1033g
T4
CH3OC(═O)—
H
1033h
T4
CH3OC(═O)—
F
1034a
T1
CH3COO—
H
1034b
T1
CH3COO—
F
1034c
T2
CH3COO—
H
1034d
T2
CH3COO—
F
1034e
T3
CH3COO—
H
1034f
T3
CH3COO—
F
1034g
T4
CH3COO—
H
1034h
T4
CH3COO—
F
1035a
T1
CH3OCOO—
H
1035b
T1
CH3OCOO—
F
1035c
T2
CH3OCOO—
H
1035d
T2
CH3OCOO—
F
1035e
T3
CH3OCOO—
H
1035f
T3
CH3OCOO—
F
1035g
T4
CH3OCOO—
H
1035h
T4
CH3OCOO—
F
1036a
T1
CH3C(═O)S—
H
1036b
T1
CH3C(═O)S—
F
1036c
T2
CH3C(═O)S—
H
1036d
T2
CH3C(═O)S—
F
1036e
T3
CH3C(═O)S—
H
1036f
T3
CH3C(═O)S—
F
1036g
T4
CH3C(═O)S—
H
1036h
T4
CH3C(═O)S—
F
1037a
T1
CH3C(═O)NH—
H
1037b
T1
CH3C(═O)NH—
F
1037c
T2
CH3C(═O)NH—
H
1037d
T2
CH3C(═O)NH—
F
1037e
T3
CH3C(═O)NH—
H
1037f
T3
CH3C(═O)NH—
F
1037g
T4
CH3C(═O)NH—
H
1037h
T4
CH3C(═O)NH—
F
1038a
T1
CH3NHC(═O)—
H
1038b
T1
CH3NHC(═O)—
F
1038c
T2
CH3NHC(═O)—
H
1038d
T2
CH3NHC(═O)—
F
1038e
T3
CH3NHC(═O)—
H
1038f
T3
CH3NHC(═O)—
F
1038g
T4
CH3NHC(═O)—
H
1038h
T4
CH3NHC(═O)—
F
1039a
T1
CH3C(═NOH)—
H
1039b
T1
CH3C(═NOH)—
F
1039c
T2
CH3C(═NOH)—
H
1039d
T2
CH3C(═NOH)—
F
1039e
T3
CH3C(═NOH)—
H
1039f
T3
CH3C(═NOH)—
F
1039g
T4
CH3C(═NOH)—
H
1039h
T4
CH3C(═NOH)—
F
1040a
T1
CH3C[═N—N(CH3)2]—
H
1040b
T1
CH3C[═N—N(CH3)2]—
F
1040c
T2
CH3C[═N—N(CH3)2]—
H
1040d
T2
CH3C[═N—N(CH3)2]—
F
1040e
T3
CH3C[═N—N(CH3)2]—
H
1040f
T3
CH3C[═N—N(CH3)2]—
F
1040g
T4
CH3C[═N—N(CH3)2]—
H
1040h
T4
CH3C[═N—N(CH3)2]—
F
1041a
T1
H
1041b
T1
F
1041c
T2
H
1041d
T2
F
1041e
T3
H
1041f
T3
F
10410g
T4
H
1041h
T4
F
1042a
T1
CH3C[═N—OCH3]—
H
1042b
T1
CH3C[═N—OCH3]—
F
1042c
T2
CH3C[═N—OCH3]—
H
1042d
T2
CH3C[═N—OCH3]—
F
1042e
T3
CH3C[═N—OCH3]—
H
1042f
T3
CH3C[═N—OCH3]—
F
1042g
T4
CH3C[═N—OCH3]—
H
1042h
T4
CH3C[═N—OCH3]—
F
1043a
T1
CH3OC(═O)NH—
H
1043b
T1
CH3OC(═O)NH—
F
1043c
T2
CH3OC(═O)NH—
H
1043d
T2
CH3OC(═O)NH—
F
1043e
T3
CH3OC(═O)NH—
H
1043f
T3
CH3OC(═O)NH—
F
1043g
T4
CH3OC(═O)NH—
H
1043h
T4
CH3OC(═O)NH—
F
1044a
T1
CH3NHC(═O)O—
H
1044b
T1
CH3NHC(═O)O—
F
1044c
T2
CH3NHC(═O)O—
H
1044d
T2
CH3NHC(═O)O—
F
1044e
T3
CH3NHC(═O)O—
H
1044f
T3
CH3NHC(═O)O—
F
1044g
T4
CH3NHC(═O)O—
H
1044h
T4
CH3NHC(═O)O—
F
1045a
T1
CH3NHC(═O)NH—
H
1045b
T1
CH3NHC(═O)NH—
F
1045c
T2
CH3NHC(═O)NH—
H
1045d
T2
CH3NHC(═O)NH—
F
1045e
T3
CH3NHC(═O)NH—
H
1045f
T3
CH3NHC(═O)NH—
F
1045g
T4
CH3NHC(═O)NH—
H
1045h
T4
CH3NHC(═O)NH—
F
1046a
T1
CH3S(═O)2NH—
H
1046b
T1
CH3S(═O)2NH—
F
1046c
T2
CH3S(═O)2NH—
H
1046d
T2
CH3S(═O)2NH—
F
1046e
T3
CH3S(═O)2NH—
H
1046f
T3
CH3S(═O)2NH—
F
1046g
T4
CH3S(═O)2NH—
H
1046h
T4
CH3S(═O)2NH—
F
1047a
T1
CH3NHS(═O)2—
H
1047b
T1
CH3NHS(═O)2—
F
1047c
T2
CH3NHS(═O)2—
H
1047d
T2
CH3NHS(═O)2—
F
1047e
T3
CH3NHS(═O)2—
H
1047f
T3
CH3NHS(═O)2—
F
1047g
T4
CH3NHS(═O)2—
H
1047h
T4
CH3NHS(═O)2—
F
1048a
T1
NH2—
H
1048b
T1
NH2—
F
1048c
T2
NH2—
H
1048d
T2
NH2—
F
1048e
T3
NH2—
H
1048f
T3
NH2—
F
1048g
T4
NH2—
H
1048h
T4
NH2—
F
1049a
T1
(CH3)2N—
H
1049b
T1
(CH3)2N—
F
1049c
T2
(CH3)2N—
H
1049d
T2
(CH3)2N—
F
1049e
T3
(CH3)2N—
H
1049f
T3
(CH3)2N—
F
1049g
T4
(CH3)2N—
H
1049h
T4
(CH3)2N—
F
1050a
T1
(CH3)3Si—
H
1050b
T1
(CH3)3Si—
F
10450c
T2
(CH3)3Si—
H
1050d
T2
(CH3)3Si—
F
1050e
T3
(CH3)3Si—
H
1050f
T3
(CH3)3Si—
F
1050g
T4
(CH3)3Si—
H
1050h
T4
(CH3)3Si—
F
1051a
T1
(CH3O)3Si—
H
1051b
T1
(CH3O)3Si—
F
1051c
T2
(CH3O)3Si—
H
1051d
T2
(CH3O)3Si—
F
1051e
T3
(CH3O)3Si—
H
1051f
T3
(CH3O)3Si—
F
1051g
T4
(CH3O)3Si—
H
1051h
T4
(CH3O)3Si—
F
A Groups. Connection is to bond on left.
and a pharmaceutically acceptable salt, ester, or N-oxide thereof.

### Claim 21 (depends on 1)

A pharmaceutical composition comprising a compound according to claim 1, or a pharmaceutically acceptable salt, ester, or N-oxide thereof, and a pharmaceutically acceptable carrier.

### Claim 22 (depends on 1)

A method of treating a microbial infection in a mammal comprising administering to the mammal an effective amount of a compound according to claim 1, or a pharmaceutically acceptable salt, ester, or N-oxide thereof.

### Claim 23 (depends on 22)

The method according to claim 22 wherein the compound is administered orally, parenterally, or topically.

### Claim 24 (depends on 1)

A medical device containing a compound, or a pharmaceutically acceptable salt, ester, or N-oxide thereof, according to claim 1.

### Claim 25 (depends on 24)

The medical device according to claim 24, wherein the device is a stent.
